View Archive »
About The Cover
The cover for issue 38 of Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from DiMasi et al [2016]," by Katayama, et al.
|
|
Table of Contents
Research Perspectives
|
| Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy |
|
https://doi.org/10.18632/oncotarget.27745
Nancy D. Ebelt, Vic Zamloot, Edwin R. Manuel
|
| 3486-3488 |
Research Papers
|
| A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? |
|
https://doi.org/10.18632/oncotarget.27727
Erryk S. Katayama, Jonathan J. Hue, David L. Bajor, Lee M. Ocuin, John B. Ammori, Jeffrey M. Hardacre, Jordan M. Winter
|
| 3489-3501 |
|
| Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness |
|
https://doi.org/10.18632/oncotarget.27748
Ashley J. Smuder, Brandon M. Roberts, Michael P. Wiggs, Oh Sung Kwon, Jeung-Ki Yoo, Demetra D. Christou, David D. Fuller, Hazel H. Szeto, Andrew R. Judge
|
| 3502-3514 |
|
| Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients |
|
https://doi.org/10.18632/oncotarget.27724
Michela Terlizzi, Antonio Molino, Chiara Colarusso, Pasquale Somma, Ilaria De Rosa, Jacopo Troisi, Giovanni Scala, Rosario Salvi, Aldo Pinto, Rosalinda Sorrentino
|
| 3515-3525 |
|
| A low psoas muscle volume is associated with a poor prognosis in penile cancer |
|
https://doi.org/10.18632/oncotarget.27719
Daiji Takkamoto, Takashi Kawahara, Takashi Tokita, Jun Kasuga, Yasushi Yumura, Hiroji Uemura
|
| 3526-3530 |
Reviews
|
| Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies |
|
https://doi.org/10.18632/oncotarget.27730
Fleury Augustin Nsole Biteghe, Neelakshi Mungra, Nyangone Ekome Toung Chalomie, Jean De La Croix Ndong, Jean Engohang-Ndong, Guillaume Vignaux, Eden Padayachee, Krupa Naran, Stefan Barth
|
| 3531-3557 |
Corrections
|
| Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion |
|
https://doi.org/10.18632/oncotarget.27754
Tzu-Hsien Tsai, Cheng-Jei Lin, Sarah Chua, Sheng-Ying Chung, Cheng-Hsu Yang, Meng-Shen Tong, Chi-Ling Hang
|
| 3558-3558 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
